Alkem Laboratories has announced the appointment of Mr. Chanakya Misra to a senior management position, effective from 18th May 2026. This strategic move is part of the company’s ongoing efforts to strengthen its leadership team and drive growth in the competitive pharmaceutical sector.
Mr. Misra, who holds an MBA in Marketing & International Business and a Bachelor of Pharmacy from IIT (BHU), brings over 25 years of professional experience to the role. His extensive background spans various sectors, including pharmaceuticals, public health, rare diseases, and healthcare ecosystems. This diverse expertise is expected to contribute significantly to Alkem Laboratories‘ strategic objectives and operational excellence.
The appointment is in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The company has provided the necessary details as required under these regulations, ensuring transparency and compliance.
Alkem Laboratories has made this information available on its official website, reflecting its commitment to keeping stakeholders informed about key organisational changes.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).